United Cannabis Corporation Reports Record Sales of its Prana Line

United Cannabis Corporation

Companies Mentioned:

Primary Exchange: OTC:BB
Under the Symbol: CNAB

United Cannabis Corporation Reports Record Sales of its Prana Line

Friday, October 28, 2016 2:25 PM

Harborside Healthcare Achieves Strongest Week To Date

DENVER, CO / ACCESSWIRE / October 28, 2016 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that its partner in California, Harborside Healthcare, reported record sales of its Prana products.

Tony Verzura, the Company's Chief Technology Officer, commented on the announcement, "Over a year ago we started with a temporary pop up store inside Harborside Health in Oakland California. By working directly with the staff and patients over a period of months, we were able to establish a track record of results for our Prana Bio Medicinals, and patients started to enroll in our A.C.T. Now Program."

The A.C.T Now program is a free, program offering a customized combination of plant-derived Prana products, nutritional guidelines, nursing support, delivery services and electronic medical chart management. Each patient is assigned to a nurse with an online HIPAA compliant patient portal to schedule consultations, make follow up appointments, review conditions in a 3-D medical library, and access to customized cannabinoid sequencing charts.

Veruza went on to say, "Harborside Health Center is the gold standard for patient care, and this growth in revenue is a direct result of the positive effect that Prana is having on the lives of their patients."

About United Cannabis Corporation

The Company's Prana Bio Medicinal products provide patients a way to mix/match cannabinoids for therapeutic purpose. These products, licensed to regulated marijuana dispensaries, are broken into 5 categories that are available in capsules, sublingual's, and topical delivery methods. The Company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability.

For further information, please visit www.unitedcannabis.us.

Contact: [email protected]
Phone: 303-386-7321

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors, created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: United Cannabis Corporation